Your shopping cart is currently empty

BCMA CARmRNA encodes a CAR protein targeting human BCMA and induces temporary CAR expression in T cells without the necessity for permanent genetic modification. It is used in cancer research as it targets BCMA, a member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17), also known as B-cell maturation antigen (CD269). This receptor supports B-cell survival and plays a role in regulating humoral immunity. Notably, BCMA is highly expressed in multiple myeloma and serves as a biomarker for its diagnosis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BCMA CARmRNA encodes a CAR protein targeting human BCMA and induces temporary CAR expression in T cells without the necessity for permanent genetic modification. It is used in cancer research as it targets BCMA, a member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17), also known as B-cell maturation antigen (CD269). This receptor supports B-cell survival and plays a role in regulating humoral immunity. Notably, BCMA is highly expressed in multiple myeloma and serves as a biomarker for its diagnosis. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.